Anderson Raymond 4
4 · Monopar Therapeutics · Filed Jul 3, 2023
Insider Transaction Report
Form 4
Anderson Raymond
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2023-06-30−2,534→ 5,066 total→ Common Stock (2,534 underlying) - Exercise/Conversion
Common Stock
2023-06-30+2,534→ 21,797 total
Footnotes (2)
- [F1]Represents shares acquired on vesting and settlement of restricted stock units.
- [F2]On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.